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Abstract
OBJECTIVE: To collect and screen for ethnophar-
macological properties (antileishmanial, antibacte-
rial and brine lethality assays) of medicinal plant
Ocimum basilicum from Peshawar region (34.008
latitude and 71.57 altitudes).
METHODS: In the present study a general antileish-
manial activity against Leishmania tropica strain
was carried out. The antibacterial potential of the
plant was performed against 06 gram positive
and 06 gram negative bacteria. Brine shrimp cyto-
toxicity assay at different concentrations were in-
vestigated.
RESULTS: The anti-promastigotes profile of the
plant showed good antileishmanial activity exhibit-
ed LC50 value 21.67 µg/mL. The result for gram posi-
tive antibacterial activity revealed that the O. basili-
cum leaves extract possesses significant inhibitory
activity at highest two concentrations ranging from
20.66 ± 0.31 to 31.86 ± 0.80 for Clostridium perfrin-
gens type C and Bacillus subtitilis, respectively, as
compared to the gentamycin (27.36 ± 0.55 and
21.80 ± 0.72, respectively). For gram negative bacte-
ria good activity was observed. A highest zone of
inhibition was recorded for Pseudomonas aerogino-
sa (28.83±0.28) at thehighest concentration (10 mg/
mL). The LC50 value obtained for brine shrimp lethal-
ity assay was 91.56 µg/mL.
CONCLUSION: The herb basil possesses effective ci-
dal activities which make this plant a good candi-
date for the isolation of antiprotozoal and antibac-
terial compounds which may lead to the develop-
ment of novel drug.
© 2015 JTCM. All rights reserved.
Key words: Ocimum basilicum; Cytotoxicity tests,
immunologic; Anti-bacterial agents; Antileishman-
ial activity
INTRODUCTION
Research on medicinal plants is exponentially growing
all over the world because of the quest for novel thera-
peutants. Traditional medicines, such as Greeo-Islam-
ic, Chinese, Ayurvedic have been developed in many
cultures that pertain to the use of different herbs and
their preparations against various diseases. Medicinal
plants are rich in such components that can be exploit-
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ed for beneficial use, for example the first anticancer
drugs (vincristine and vinblastine) for human were iso-
lated from Catharanthus roseus.1 Out of the 250 000-
500 000 plants estimated in the world; a large propor-
tion of them is unexplored for medicinal potential.2
Natural and unprocessed products have been used for
the treatment of human infections since long time and
possessed by common notion, i.e. "Generally Recog-
nized as Safe" (GRAS).3,4 Biologically active com-
pounds with therapeutic potential are isolated from dif-
ferent resources, especially from plants.5-7 Pharmacologi-
cal activities give a little insight about the medicinal po-
tential of the plants and therefore, considered inevita-
ble in the search for novel drugs.
Ocimum basilicum is a medicinally important plant
that belongs to Lamiaceae family. The plant is widely
grown as aromatic crop for the production of aromatic
oils, dry leaves and also for ornamental purposes.8 The
local names used to describe O. basilicum is "Kashma-
lu" in the Pashto language, "Reihan" and "Niazbu" in
Urdu language, "Al-Reihan"in Arabic language and
"Sweet basil" in English language.4 O. basilicum is na-
tive to tropical and subtropical regions; and found in
Asia, Africa and South America. The genus Ocimum
consists of 50-150 species.9 O. basilicum is a stout,
bushy and aromatic culinary herb having loose ra-
cemes.10 More than 42.5 tonnes oil is produced from
O. basilicum annually.11 The genus Ocimum exhibits
significant variation among its different species, in
terms of morphology, growth, habit, color of follower,
leaves and chemical composition which is attributed to
the ease in cross pollination.12 Traditionally O. basili-
cum is used for many diseases like cerebral strokes, hy-
pertension, alcohol intoxication, anxiety, migraines,
menstrual cramps, carminative, galactagogue, gum ul-
cers, kidney problems, acne, improving blood circula-
tion, diabetics, eye diseases, insomnia and mouth
sores.3,4,13-16 O. basilicum is also famous for the presence
of aromatic oils and antioxidants.17,18 Some of the phe-
nolic compounds found in O. basilicum is rosmarinic
acid, caffiec acid, vanillic acid, Lithospermic acid, hy-
droxy benzoic acid, p-coumaric acid, ferulic acid and
gentisic acid.19,20
In the last decades antibiotics' had lost their efficacy
due to drug resistance. Novel therapeutants are not pro-
duced at the pace to which microorganisms becoming
resistant. In addition, there is a significant need for a
health care system in developing countries which could
be cheaper and affordable.4 Therefore, the current
study was carried out to collect and screen for ethno-
pharmacological properties (antileishmanial, antibacte-
rial and brine lethality assays) of medicinal plant O.
basilicum from Peshawar region (34.008 latitude and
71.570 altitudes).
MATERIALS ANDMETHODS
Antibacterial activity
Bacterial strains crude methanolic extract of O. basili-
cum was investigated against thirteen bacterial strains
collected from various institutes (Table 1), including
Klebsiella pneumoniae, Staphylococcus aureus, Pseudo-
monas aeroginosa, Escherichia coli (human source),
Salmonella typhi, Salmonella typhimurium (veterinary
source), Bacillus subtilis, Enterococcus faecalis, Xan-
thomonas campestris, Clostridium perfringens type C,
Clostridium perfringens type D and Clostridium chau-
voei. All the bacterial strains were collected in sterile
nutrient agar slants and sub-cultured on Oxoid nutri-
ent agar media (CM0309).
Plant material
The plant material was collected from Peshawar (Mul-
lazai) and identified at Department of Botany, Univer-
sity of Peshawar. The leaves were excised, washed with
distill water and shade dried. Using an electrical grind-
ing machine (MJ-176NR, Matsu-shita electric Inc.,
Co., Ltd., Osaka, Japan) the dried leaves were ground.
The ground mass of about 116 g was kept in sterile re-
agent bottle of 1000 mL while methanol was added to
soak the sample. The test sample was kept in methanol
for 7 days and stirred gently twice a day. The viscous
extracts were dried in water bath and stored at 4 ℃ .
Different dilutions of the test sample were made in Di-
methyl sulfoxide (DMSO). The final concentrations of
the crude extract in DMSO (test dilutions) were 1, 3,
6 and 10 mg/mL.
Culture procedure
The bacterial cultures were standardized as described
by Baker et al.21 Briefly 1 mL of nutrient broth con-
Strain
Klebsiella pneumonia, Bacillus subtilis
Escherichia coli, Pseudomonas aeroginosa, Staphylococcus
aureus, Salmonella typhi, Enterococcus faecalis
Clostridium perfringens type D, Clostridium perfringens type C,
Escherichia coli, Salmonella typhimurium, Clostridium chauvoei,
Xanthomonas campestris
Leishmania tropica kwh23
Institute
Centre of Biotechnology and Microbiology, University of
Peshawar, Khyber Pakhtunkhwa Pakistan
Khyber Teaching Hospital, Khyber Pakhtunkhwa Pakistan
Veterinary Research Institute, Khyber Pakhtunkhwa Pakistan
Agriculture University, Khyber Pakhtunkhwa Pakistan
Department of Biotechnology, Quaid-i-Azam University,
Islamabad, Pakistan
Table 1 Collection of test strains of bacteria and Leishmania
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tained in sterilized test tubes was added in 1 mL of 24 h
broth culture of bacteria. Sterilized water was added to
adjust the turbidity with McFarland standards. The tur-
bidity was adjusted visually. 0.5 McFarland standard re-
lates to the Escherichia coli suspension of 1.5×108 cells/
mL.
In vitro agar well diffusion assay for anti bacterial
activity
Agar well diffusion method as described by Khalil et al 22
was used to determine the inhibitory zones. Shortly;
from the already standardized culture, 1 mL of the test
sample was poured on the agar plates. Uniform micro-
bial lawns were prepared by using bent spreader. Excess
of inoculum was removed using sterile cotton swabs.
6mm borer was used to make wells in the culture me-
dia. 50 µL of test sample was introduced into the wells.
Standard gentamycin discs (10 µg) were used as posi-
tive control while DMSO was used as negative control.
The test plates were incubated at 37 ℃ for 24 h. Clear
zones of inhibition were measured in millimeters using
vernier calipers. The assay was performed with stan-
dard microbiology practices in triplicate.
In vitro antileishmanial susceptibility test
L. tropica strain were cultured in Medium 199 contain-
ing 10% heat inactivated Fetal Bovine Serum at 24 ℃
for about 7 days to obtain a culture of 1×106 parasite
per milliliter according to the procedure described by
Khan et al 22 with minor modification. Briefly, stock so-
lution (10 000 µg/mL) of the test sample was prepared
in DMSO. The culture was transferred to each well of
96-well plate. The activity was performed at different
concentration ranging from 1000 to 0.005 ppm. The
first well of the plate contained 1000 µg/mL; second
700 µg/mL and 3rd well 500 µg/mL. The serial dilu-
tion of the test samples was carried out for 500 µg/mL.
For positive and negative controls, Amphotericin B
(Amp B) and DMSO were maintained respectively.
The titer plate was incubated for 48 h at 24 ℃. The as-
say was performed in triplicate. The percent mortality
of the test and standard drug were observed after 48 h.
The live parasites were counted by transferring 15 µL
of culture to improved Neubauer chamber and ob-
served under light microscope. The percent (%) surviv-
al of the culture was confirmed by using 4% trypan
blue. Finally, the data were analyzed using GraphPad
Prism (Graphpad Prism software Version 5.0, Graph-
Pad software Inc, CA, USA).
Brine shrimp cytotoxicity assay
In vitro cytotoxicity assay was performed according to
the standardized protocol of Ali et al.6 Briefly, a stock
solution of the test sample was prepared by dissolving
10 mg of the plant extract in 1 mL of DMSO. The
eggs of the brine shrimp were hatched in a tray contain-
ing artificial sea salt water (4% NaCl) at 25 ℃. A total
of 10 brine shrimp was collected from the fool and
transferred to each vial containing sea salt water and
test samples at different concentrations. Positive con-
trol and negative control were maintained containing
doxorubicin and DMSO, respectively. The vials were
incubated at 25 ℃ for 24 h. After the specified time,
percent mortality was recorded and the results were
subjected to GraphPad Prism (Graphpad Prism soft-
ware Version 5.0, GraphPad software Inc, California,
USA) for LC50 calculation.
RESULTS
For the antileishmanial activity of O. basilicum at the
concentration of 1000, 700 and 500 ppm, its extract
and Amp B exhibited 100% mortality and at reduced
concentrations (50 and 5 µg/mL) plant extract demon-
strated good antileishmanial potential i.e. 77.2% ±
5.2% and 11.5% ± 4.3%, respectively. In contrast, Amp
B exhibited 100%, 95.0% ± 3.8%, 62.5% ± 1.1% and
50.0% ± 0.6% mortality at 50, 5, 0.5 and 0.05 µg/mL,
respectively. L. tropica showed resistance to both plant
extract and Amp B at 0.5 µg/mL and below (Figure 1).
The LC50 value of plant extract and Amp B is 21.67
and 0.06 µg/mL, respectively (Table 2).
For the antibacterial potential of the plant extract
against 06 gram positive bacterial strains at different
concentrations (50, 150, 300 and 500 µg) ( Table 3),
Test sample
Plant
Amp B
0.005
0
0
0.05
0
50.0±0.6a
0.5
0
62.5±1.1a
5
11.5±4.3a
95.0±3.8
50
77.2±5.2a
100
500
100
100
700
100
100
1000
100
100
LC50
21.67
0.06
Notes: plant: O. basilicum leaves; Amp B: amphotericin B; LC50: lethal concentration. Values are means and standard deviation of three
replicates; lower case letters shows significance difference within groups; means sharing a letter in common are not significantly different at
P > 0.05; means sharing no letter in common are significantly different at P < 0.05.
Table 2 Antileishmanial activity of crude leaves methanolic extract of O. basilicum (µg/mL, xˉ ± s)
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y=﹣0.1153x + 93.613
R2 = 0.9065
Figure 1 Antileishmanial activity exhibited by O. basilicum
against L. tropica promastigotes
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at the concentration 50 and 150 µg, the plant extract
exhibited non significant activity. As expected, at high-
est concentration 300 and 500 µg, test samples dis-
played significant activity against all the strains com-
pared to the Gentamycin 27.36 ± 0.55 and 21.80 ±
0.72, respectively. No significant difference (P > 0.05)
was detested between the strains at 500 µg concentra-
tions except Clostridium chauvoei (P < 0.05). The
highest activity was recorded against Bacillus subtilis
(31.86 ± 0.80). Subsequently, the test sample was test-
ed against 06 gram negative bacteria, and the results
are summarized in Table 4. The test sample showed no
significant activity at lowest concentration (50 and
150 µg), while at the highest concentration of the test
sample exhibited significant activity (P < 0.05) apart
from Salmonella typhimurium and Xanthomonas
campestris (P > 0.05). The highest zone of inhibition
was observed for Pseudomonas aeroginosa (28.83 ±
0.28) followed by Escherichia coli (28.30 ± 0.83) at
concentration 500 µg/mL.
For the brine shrimp cytotoxicity potential of the
plant extract at concentrations 500, 300, 100, 50
and 20 µg/mL (Table 5), the extract was safe up to
50 µg/mL, exhibiting zero percent mortality. The
LC50 value obtained for the extract and doxorubicin
(positive control) was 91.56 and 2.58 µg/mL, respec-
tively. The mortality rates of the test samples are shown
in Figure 2.
DISCUSSION
Current study was performed to examine the hidden
potential of crude methanolic extract of leaves of O.
basilicum against L. tropica. The assessed methanolic
extract of basil has a significant inhibitory effect on L.
tropica strain (LC50 21.67). Previous study demonstrat-
ed the leaves acetone and methanolic extract of O. basi-
licum has moderate activity LC50 (69 ± 8) and (112 ±
14) µg/mL, respectively, against L. donovani.28 We
have found that antileishmanial potential of O. basili-
cum against L. tropica has increased up to twofold.
Pathogenic bacteria are considered as a key cause of
morbidity and mortality in human beings. Though,
pharmaceutical companies have launched a number of
antibacterial in last few decades but emergence of resis-
tance to these drugs threaten the scientific community
and become a global concern. The antibacterial poten-
tial of basil has already been reported of both basil oil
and its extract against gram positive and gram negative
bacteria.30,31 The inhibitory zone produces against gram
negative bacteria by the basil at the highest concentra-
tion (500 µg/mL) are good enough to compare with
Gram negative Bacterial
strain
Klebsiella pneumonia
Pseudomonas aeruginosa
E. coli (human source)
E. coli (veterinary source)
Salmonella typhi
Salmonella typhimurium
Xanthomonas
Concentration used (mg/mL)
1
1.26±0.40b
3.23±0.29
2.33±0.87a
0
1.46±0.20b
2.26±0.59a
1.33±0.99b
3
8.36±0.54
6.23±0.28a
10.96±0.93
0
2.93±0.73a
5.26±0.52b
4.26±0.26b
6
24.86±0.44a
21.80±0.53b
24.53±0.93a
13.86±0.22
21.60±0.32b
12.40±0.29
9.30±0.11
10
26.66±0.30
28.83±0.28a
28.30±0.83a
20.53±0.55
24.93±0.93
15.30±0.17b
14.36±0.83b
Gentamycin (10 µg)
10
16.06±0.58a
21.73±0.25
27.96±0.49b
16.20±0.72a
23.83±0.37c
28.30±0.43b
24.26±0.30c
Table 4 Antibacterial activity of crude methanolic extract of O. basilicum leaves against gram negative bacteria (n = 3, xˉ ± s)
Notes: values are means and standard deviation of three replicates; lower case letters shows significance difference within groups; means
sharing a letter in common are not significantly different at P > 0.05; means sharing no letter in common are significantly different at P <
0.05.
Bacterial strain
Bacillus subtilis
Enterococcus
Staphylococcus aureus
Clostridium perfringens type C
Clostridium perfringens type D
Clostridium chauvoei
Concentrations used
50
2.96±0.15a
1.26±0.44
1.73±0.25b
2.33±0.35ab
3.93±0.83
2.33±0.75ab
150
12.4±0.76a
6.00±0.22b
5.26±0.39b
10.23±0.97
14.23±0.25
12.70±0.36a
300
25.56±0.51a
28.86±1.02
22.96±0.45b
20.66±0.31c
21.83±0.23bc
24.73±0.46a
500
31.86±0.80a
30.73±0.64a
30.66±0.57a
31.13±0.23a
30.33±0.20ab
29.20±0.66b
Gentamycin (positive control)
10
27.36±0.55a
27.23±0.32a
24.13±0.85b
21.80±0.72c
23.10±0.40bc
19.86±0.77
Notes: values are means and standard deviation of three replicates; lower case letters shows significance difference within groups; means
sharing a letter in common are not significantly different at P > 0.05; means sharing no letter in common are significantly different at P <
0.05.
Table3Antibacterialactivityofcrude leavesmethanolicextractofO.basilicumagainstgrampositivebacteria (n=3,µg/mL, xˉ ± s)
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gentamycin. While at lowest (50 and 150 µg/mL) con-
centrations, bacteria showed resistance. In contrast,
gram positive bacteria are more susceptible to the ex-
tract and significantly (P < 0.05) inhibit bacteria com-
pared to gentamycin. Similar reports have been ob-
served for same bacterial strains. 32-37The results were al-
so in agreement with Simin et al 23 finding oils of basili-
cum to be more effective against gram positive strains.
Among all the strains used, the more susceptible strain
was gram positive B. subtitilis (31.86 ± 0.80), which re-
corded highest zone of inhibition. Contrary to the cur-
rent findings, some authors reported antibacterial activ-
ity of O. basilicum to be more against gram negative
bacteria as compared to gram positive bacteria.37-39
Brine shrimp lethality test signifies a simple, inexpen-
sive and rapid bioassay for bioactivity investigation of
plant extracts which show a relationship to anti-tumor
and cytotoxic properties. In the current study, brine
shrimp lethality assay of basil performed, and showed
good cytotoxic activity having LC50 91.56 µg/mL. simi-
lar result was observed for the essential oil obtained
from basil (LC50 90 µg/mL).40 While the present find-
ing is differ with the finding of Gadir, (2012) in which
leaves ethanolic extract exhibited LC50 values > 1000 µg/
mL.41 In another study, the LC50 value obtained was
2693.355 and 1230.244 µg/mL for crude leaves and
stem methanolic extract of basil, respectively.42 The dif-
ference in results may be attributed to methods used i.
e. well diffusion and disc diffusion assays,37,43 phytogeo-
graphical regions23 and also the geographical location
in which the experiment is conducted.37 Composition
of basil contents varies with the seasonal variations32 is
another factor that could contribute to variation in re-
sults.
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